• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
IXC

INVEX THERAPEUTICS LTD - Charts / Financials

2.27% ! 9.0¢
Market Cap $6.763M  !

Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical... Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical development Company with issued patents and multiple orphan drug designations focused on the repurposing of an already approved drug, Exenatide, for efficacious treatment of neurological conditions derived from or involving raised intracranial pressure. Our primary focus is on the orphan disease Idiopathic Intracranial Hypertension (IIH), a large and growing market opportunity with no regulatory cleared treatmentsMore

refresh Created with Sketch. REFRESH
Day
Open 8.8¢   Day High 9.0¢   Day Low 8.8¢
Daily Volume 95000
Bids   Sellers
Number Price Volume   Number Price Volume
1 8.3¢ 42086   1 9.7¢ 9000

Directors & Senior Management

Ms. Narelle Warren Chief Financial Officer, Company Secretary
Ms. Carol Parish Chief Operating Officer
Dr. Thomas Duthy Executive Director
Mr. David Mcauliffe Interim Non-Executive Chairman of the Board
Mr. David Colin Wheeler Non-Executive Director

Data source: Refinitiv

Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
9.0¢
Change
0.002(2.27%)
Mkt cap ! $6.763M
Open High Low Value Volume
8.8¢ 9.0¢ 8.8¢ $8.48K 95K

Buyers (Bids)

No. Vol. Price($)
1 42086 8.3¢
 

Sellers (Offers)

Price($) Vol. No.
9.7¢ 9000 1
View Market Depth
Last trade - 11.50am 18/07/2025 (20 minute delay) ?
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.